TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $125,000 | -3.8% | 7,630 | -1.0% | 0.00% | – |
| Q2 2021 | $130,000 | -65.5% | 7,710 | -62.7% | 0.00% | -100.0% |
| Q1 2021 | $377,000 | +3.6% | 20,670 | +3.1% | 0.00% | 0.0% |
| Q4 2020 | $364,000 | +25.5% | 20,050 | +23.7% | 0.00% | 0.0% |
| Q3 2020 | $290,000 | +9.8% | 16,210 | +10.6% | 0.00% | 0.0% |
| Q2 2020 | $264,000 | +17.3% | 14,655 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $225,000 | -18.5% | 14,655 | +4.6% | 0.00% | – |
| Q4 2019 | $276,000 | +34.0% | 14,005 | +16.7% | 0.00% | – |
| Q3 2019 | $206,000 | +1.5% | 12,005 | +20.7% | 0.00% | – |
| Q1 2019 | $203,000 | – | 9,950 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |